Trudell Medical Limited has entered into an agreement to acquire the respiratory diagnostics business unit (RDx) from Vyaire Medical. RDx, renowned for its pulmonary function testing equipment used in hospitals and private clinics worldwide, will strengthen Trudell Medical’s market position in respiratory health and delivery devices. The acquisition, subject to court approval, is anticipated to close within 8-12 weeks. Following the acquisition, RDx will continue to operate separately, maintaining its operations in Germany and California. This strategic purchase is viewed as a continuation of service to RDx’s customers, aligning well with Trudell’s ‘Patient First’ philosophy. Vyaire Medical had filed for Chapter 11 bankruptcy earlier in the year and aimed to liquidate its business units to financially stable buyers. The transaction underscores the long-standing relationship between the companies, with Trudell being a distributive partner for Vyaire’s products in Canada.
Healthcare, Medical Devices,Canada, United States, Germany
https://contentapi.cision.com/api/v1.0/releases/20240822EN84196